Remove Aortic Remove Aortic valve Remove Pulmonary
article thumbnail

Prognostic implications of pulmonary vascular resistance in transcatheter aortic valve implantation

Heart BMJ

Pulmonary hypertension (PH) is a complex and progressive disorder characterised by elevated pulmonary artery pressure. Transcatheter aortic valve implantation (TAVI) is a minimally invasive surgical procedure that has revolutionised the treatment of severe aortic stenosis (AS).

article thumbnail

Artificial intelligence-enabled phenotyping of patients with severe aortic stenosis: on the recovery of extra-aortic valve cardiac damage after transcatheter aortic valve replacement

Open Heart

Objective A novel artificial intelligence-based phenotyping approach to stratify patients with severe aortic stenosis (AS) prior to transcatheter aortic valve replacement (TAVR) has been proposed, based on echocardiographic and haemodynamic data. ±15.8 ±15.1 mm Hg, p value: 0.0079).

article thumbnail

Updated definition of pulmonary hypertension and outcome after transcatheter aortic valve implantation

Heart BMJ

Objective The European Society of Cardiology guidelines have recently defined new cut-offs for pulmonary hypertension (PH) and pulmonary vasculature resistance (PVR; median pulmonary artery pressure (mPAP) >20 instead of 25 mm Hg and PVR >2 instead of 3 Wood unit). Overall median age was 82 years, while 55.3%

article thumbnail

Long?Term Outcomes After Transcatheter Aortic Valve Implantation in Patients With Chronic Inflammatory Disease

Journal of the American Heart Association

BackgroundChronic inflammatory disease (CID) accelerates atherosclerosis and the development of aortic stenosis. Data on longā€term outcomes after transcatheter aortic valve implantation (TAVI) in those patients are missing. and 1.62, respectively).

article thumbnail

Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation

Heart BMJ

Objectives This study aimed to evaluate the prognostic value of coronary microvascular dysfunction (CMD) at long term after transcatheter aortic valve implantation (TAVI) and to explore its relationship with extravalvular cardiac damage (EVCD). CMD was defined as IMR angio ≥30 units.

article thumbnail

Reviewing the Ross Procedure with Dr. Kerendi

CTVS

The Ross procedure is a complex operation designed to replace a diseased or damaged aortic valve. This unique surgery relies on a patient’s own existing tissue, the pulmonary valve, to replace the aortic valve rather than using an artificial valve.

article thumbnail

TAVR has higher mortality rates for some patients: Study

Becker's Hospital Review - Cardiology

Pulmonary hypertension patients who undergo transcatheter aortic valve replacement are at a higher risk for mortality than those without pulmonary hypertension, according to a recent study.